Chronic cough, defined as a cough persisting beyond eight weeks, presents a significant diagnostic and therapeutic challenge in clinical practice due to its multifactorial etiology. This article aims to elucidate a comprehensive approach to diagnose and manage chronic cough effectively.
The diagnostic approach should be systematic and patient-centric. A detailed history and physical examination are crucial to identify potential etiologies. The clinician should consider common causes like gastroesophageal reflux disease (GERD), asthma, upper airway cough syndrome (UACS), and non-asthmatic eosinophilic bronchitis (NAEB). However, rare causes like lung cancer, sarcoidosis, and idiopathic pulmonary fibrosis should not be overlooked. Laboratory tests, imaging studies, and pulmonary function tests can be instrumental in identifying the underlying cause.
Management of chronic cough should be tailored based on the identified cause. For example, proton pump inhibitors may be beneficial in GERD-associated cough, while inhaled corticosteroids are the mainstay for asthma or NAEB related cough. Antihistamines and decongestants can be effective for UACS. In refractory cases or when the cause is unclear, referral to a pulmonologist or otolaryngologist may be necessary.
Education plays a pivotal role in managing chronic cough. Patients should be informed about the chronic nature of their condition, potential triggers, and the importance of adherence to therapy. Lifestyle modifications like smoking cessation, weight loss, and dietary changes can also significantly impact symptom control.
Chronic cough is a complex condition requiring a comprehensive, patient-centric approach for effective diagnosis and management. A thorough understanding of potential etiologies and appropriate therapeutic strategies can significantly improve patient outcomes. Furthermore, patient education and lifestyle modifications are crucial adjuncts to pharmacological therapy.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation